• Login
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    Search 
    •   QMRO Home
    • Search
    •   QMRO Home
    • Search
    ‌
    ‌

    Browse

    All of QMROCommunities & CollectionsBy Issue DateAuthorsTitlesSubjects
    ‌
    ‌

    Administrators only

    Login
    ‌
    ‌

    Discover

    Author
    Giovannoni, G (4)
    Marta, M (4)
    Gnanapavan, S (3)Schmierer, K (3)Turner, B (3)Thomson, A (2)Ammoscato, F (1)Baker, D (1)Bauer, A (1)Bianchi, L (1)... View MoreSubject
    Humans (4)
    Female (3)Male (3)Multiple Sclerosis (3)Adult (2)Immunologic Factors (2)Middle Aged (2)9-hole peg test (1)Aged (1)Aged, 80 and over (1)... View MoreDate Issued2020 (1)2019 (1)2017 (1)2016 (1)
    ‌
    ‌

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Search

    Show Advanced FiltersHide Advanced Filters

    Filters

    Use filters to refine the search results.

    Now showing items 1-4 of 4

    • Sort Options:
    • Relevance
    • Title Asc
    • Title Desc
    • Issue Date Asc
    • Issue Date Desc
    • Results Per Page:
    • 5
    • 10
    • 20
    • 40
    • 60
    • 80
    • 100
    Thumbnail

    Validation of an environmentally-friendly and affordable cardboard 9-hole peg test. 

    Dubuisson, N; Bauer, A; Buckley, M; Gilbert, R; Paterson, A; Marta, M; Gnanapavan, S; Turner, B; Baker, D; Giovannoni, G;... (2017-10)
    BACKGROUND: In multiple sclerosis (MS) upper limb neurological impairments, are an important driver of disability and handicap. The gold standard for assessing upper limb function is the 9-hole peg test (9HPT). One ...
    Thumbnail

    Switching patients at high risk of PML from natalizumab to another disease-modifying therapy. 

    Giovannoni, G; Marta, M; Davis, A; Turner, B; Gnanapavan, S; Schmierer, K (2016-10)
    There are several options for switching people with multiple sclerosis (MS) who are at high risk of developing progressive multifocal leukoencephalopathy (PML) from natalizumab to alemtuzumab. However, some of these have ...
    Thumbnail

    Visibility and representation of women in multiple sclerosis research. 

    Thomson, A; Horne, R; Chung, C; Marta, M; Giovannoni, G; Palace, J; Dobson, R (2019-04-09)
    OBJECTIVE: To establish the gender distribution of multiple sclerosis (MS) researchers across high-impact neurologic publications, MS-specific journals, and the European Committee for Treatment and Research in MS (ECTRIMS). ...
    Thumbnail

    CSF neurofilament light chain testing as an aid to determine treatment strategies in MS. 

    Reyes, S; Smets, I; Holden, D; Carrillo-Loza, K; Christmas, T; Bianchi, L; Ammoscato, F; Turner, B; Marta, M; Schmierer, K;... (2020-11)
    OBJECTIVE: To evaluate the use of CSF neurofilament light chain (NfL) measurements in clinical practice as well as their effect on treatment strategies and outcomes in patients with MS. METHODS: This was an observational ...
    Twitter iconFollow QMUL on Twitter
    Twitter iconFollow QM Research
    Online on twitter
    Facebook iconLike us on Facebook
    • Site Map
    • Privacy and cookies
    • Disclaimer
    • Accessibility
    • Contacts
    • Intranet
    • Current students

    Modern Slavery Statement

    Queen Mary University of London
    Mile End Road
    London E1 4NS
    Tel: +44 (0)20 7882 5555

    © Queen Mary University of London.